Sale!

Phospholipid Syndrome Panel Test

1,050 د.إ

-10%

The Phospholipid Syndrome Panel Test is a diagnostic tool used to detect the presence of antiphospholipid antibodies in the blood, which are indicative of antiphospholipid syndrome (APS). APS is an autoimmune disorder characterized by the body’s immune system mistakenly attacking normal proteins in the blood, leading to increased risk of blood clots, miscarriage, and other complications. This comprehensive panel test is crucial for diagnosing APS, monitoring the severity of the condition, and guiding treatment decisions.

At DNA Labs UAE, the cost of the Phospholipid Syndrome Panel Test is set at 1050 AED. The test is conducted in a state-of-the-art laboratory setting by a team of experienced professionals, ensuring accurate and reliable results. DNA Labs UAE is known for its commitment to quality, patient care, and the use of advanced diagnostic technologies, making it a preferred choice for individuals seeking thorough and dependable medical testing services.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PHOSPHOLIPID SYNDROME PANEL Test

The Phospholipid Syndrome Panel is a blood test that is used to diagnose and monitor patients with phospholipid syndrome, also known as antiphospholipid syndrome (APS).

APS is an autoimmune disorder that is characterized by the presence of specific antibodies that target phospholipids, which are a type of fat molecule found in cell membranes.

Test Components:

  • Cardiolipin Antibodies (IgG & IgM)
  • Phospholipid Antibodies Panel
  • Lupus Anticoagulant by dRVVT

Test Price: 1050.0 AED

Sample Condition:

4 mL (2.5 mL min.) serum from 1 SST AND 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours.

If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 min. & finally transfer the supernatant (PPP) to 1 labelled clean plastic screw-capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW.

Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.

Report Delivery:

Sample daily by 3 pm; Report next day

Method:

EIA, Electromechanical Clot Detection

Test Type:

Thromboembolic disorders, Abortions

Doctor:

Gynecologist, Physician

Test Department:

Pre Test Information

Overnight fasting is preferred. It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. Duly filled Coagulation Requisition Form (Form 15) is mandatory.

Test Details:

The Phospholipid Syndrome Panel is a blood test that is used to diagnose and monitor patients with phospholipid syndrome, also known as antiphospholipid syndrome (APS). APS is an autoimmune disorder that is characterized by the presence of specific antibodies that target phospholipids, which are a type of fat molecule found in cell membranes.

The panel typically includes the following tests:

  1. Anticardiolipin Antibodies (ACA): This test measures the levels of antibodies that target cardiolipin, a type of phospholipid found in the inner mitochondrial membrane. Elevated levels of ACA are associated with an increased risk of blood clot formation.
  2. Lupus Anticoagulant (LA): This test is used to detect the presence of antibodies that interfere with the normal clotting process. These antibodies can cause an increased risk of blood clotting and can also affect the results of other coagulation tests.
  3. Anti-Beta-2 Glycoprotein I Antibodies (anti-2GPI): This test measures the levels of antibodies that target beta-2 glycoprotein I, a protein that binds to phospholipids. Elevated levels of anti-2GPI antibodies are also associated with an increased risk of blood clot formation.

These tests are usually performed together as a panel because they provide a comprehensive assessment of the patient’s immune response to phospholipids. The results of the panel can help diagnose APS and guide treatment decisions.

It is important to note that a positive result on any of these tests does not necessarily mean that the patient has APS. Additional clinical criteria, such as a history of blood clots or pregnancy complications, are usually required for a definitive diagnosis.

Test Name PHOSPHOLIPID SYNDROME PANEL Test
Components *Cardiolipin AntibodiesIgG&IgM *PhospholipidAntibodiesPanel *Lupus AnticoagulantbydRVVT
Price 1050.0 AED
Sample Condition 4 mL (2.5 mL min.) serum from 1 SST AND3mLwholeblood in 1 Blue Top (SodiumCitrate)tube.Mix thoroughly byinversion. Transport toLabwithin 4 hours.If this is not possible, makePPP within 1 hour of collection as follows: Centrifugesampleat3600rpmfor15 min.&transfersupernatanttoaclean plastictube. Centrifugethissupernatant again at 3600 rpm for 15 min. & finally transferthesupernatant(PPP)to1 labelled cleanplasticscrewcappedvial. FREEZE IMMEDIATELY. Ship frozen. DONOTTHAW. Overnightfastingis preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Report Delivery SampleDaily by 3 pm;ReportNext day
Method EIA, Electromechanical Clot Detection
Test type Thromboembolic disorders, Abortions
Doctor Gynecologist, Physician
Test Department:
Pre Test Information Overnight fasting is preferred. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to samplingas these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician. Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Test Details

The Phospholipid Syndrome Panel is a blood test that is used to diagnose and monitor patients with phospholipid syndrome, also known as antiphospholipid syndrome (APS). APS is an autoimmune disorder that is characterized by the presence of specific antibodies that target phospholipids, which are a type of fat molecule found in cell membranes.

The panel typically includes the following tests:

1. Anticardiolipin Antibodies (ACA): This test measures the levels of antibodies that target cardiolipin, a type of phospholipid found in the inner mitochondrial membrane. Elevated levels of ACA are associated with an increased risk of blood clot formation.

2. Lupus Anticoagulant (LA): This test is used to detect the presence of antibodies that interfere with the normal clotting process. These antibodies can cause an increased risk of blood clotting and can also affect the results of other coagulation tests.

3. Anti-Beta-2 Glycoprotein I Antibodies (anti-2GPI): This test measures the levels of antibodies that target beta-2 glycoprotein I, a protein that binds to phospholipids. Elevated levels of anti-2GPI antibodies are also associated with an increased risk of blood clot formation.

These tests are usually performed together as a panel because they provide a comprehensive assessment of the patient’s immune response to phospholipids. The results of the panel can help diagnose APS and guide treatment decisions.

It is important to note that a positive result on any of these tests does not necessarily mean that the patient has APS. Additional clinical criteria, such as a history of blood clots or pregnancy complications, are usually required for a definitive diagnosis.